샘플 요청 목록

 카트 문의
시장보고서
상품코드
1808916

세계의 톡소플라즈마증 검사 시장 : 제품 유형별, 검사 유형별, 기술별, 샘플 유형별, 최종 사용자별, 국가별, 지역별 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Toxoplasmosis Testing Market, By Product Type, By Test Type, By Technology, By Sample Type, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 398 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

톡소플라즈마증 검사 시장의 규모는 2024년 12억 6,700만 달러였으며 2025년부터 2032년까지 연평균 복합 성장률(CAGR) 9.1%로 확대될 전망입니다.

톡소플라즈마증 검사 시장은 주로 혈청학적 및 분자학적 검사를 통해 톡소플라즈마 곤디 감염을 검출하는 진단 절차를 포함합니다. 시장 성장의 원동력은 면역 결핍 환자, 임산부, 장기 이식 수령인의 톡소플라즈마 증례 증가이며, 특히 위생 환경과 인지도가 낮은 지역에서 증가가 현저합니다. 특히 유럽과 남미에서는 산전 스크리닝 노력이 증가하고 있으며 진단 실험실에서 핵산 증폭 검사(NAAT)의 사용이 수요를 뒷받침하고 있습니다. 그러나 시장은 과소 보고, 제한된 공중보건 감시, 저소득 지역에서 일관성 없는 검사 관행 등의 억제 요인에 직면하고 있습니다. 기회 면에서 R&D 자금 증가, PCR 및 ELISA 플랫폼 기술 개선, 진단 회사와 공중 보건 기관(CDC 및 WHO 등)과의 협력 관계가 향후 수년간 시장 확대를 지원할 것으로 예측됩니다.

톡소플라즈마증 검사 시장 - 시장 역학

산전 스크리닝 및 진단의 진보는 톡소플라즈마증 검사 시장의 성장을 가속

톡소플라즈마증 검사 시장은 산전 케어와 감염증 관리의 중시가 높아짐에 따라 기세를 늘리고 있습니다. CDC에 따르면, 톡소플라즈마증은 미국에서 4,000만 명 이상이 앓고 있지만 대부분은 증상이 없습니다. 임산부와 면역 결핍증은 특히 위험이 높으며 프랑스, 오스트리아, 브라질 등의 국가에서는 정기적인 스크리닝 프로토콜을 시행합니다. 2023년 유럽 질병 예방관리센터(ECDC)는 선천성 감염을 줄이기 위해 동유럽에서 홍보 캠페인이 증가하고 진단법이 개선되고 있음을 강조했습니다. 동시에 WHO의 식품 매개 기생충증 등에 대한 이니셔티브는 특히 개발도상국에서 공중 보건 전략의 개선으로 이어졌습니다. 공중 보건 클리닉에서 표준화된 혈청 검사를 포함한 진단 실험실과 병원 간의 협력 관계 증가도 시장 확대에 기여합니다.

톡소플라즈마증 검사 시장 - 세분화 분석

세계의 톡소플라즈마증 검사 시장은 제품 유형, 검사 유형, 기술, 샘플 유형, 최종 사용자, 지역에 따라 세분화됩니다.

시장은 제품 유형에 따라 검사 키트, 시약, 장비 및 분석 장비, 소프트웨어 솔루션의 네 가지 범주로 나뉩니다. 검사 키트는 임상 진단 및 POC(Point of Care) 진단에 널리 사용되기 때문에 우선 순위가 가장 높습니다. 시약은 정기적인 수요에 견인되어 뒤따르고 있습니다. 그 다음 장비 및 분석장비가 뒤를 이었으며 소프트웨어 솔루션은 결과 해석에 지원 역할을 하는 동시에 새로운 역할을 담당합니다.

시장은 검사 유형에 따라 혈청학적 검사, 분자학적 검사, 조직학적 검사 및 기타 범주로 나뉩니다. 혈청학적 검사는 비용 효과와 광범위한 임상 사용으로 시장을 선도했습니다. 분자 검사는 기준 실험실에서의 채용이 증가하면서 약간의 차이로 뒤를 이었습니다. 조직학적 검사는 그다지 선호되지 않았고, 다른 검사 유형은 최소한의 시장 점유율을 차지했습니다.

톡소플라즈마증 검사 시장 - 지리적 인사이트

유럽에서는 프랑스와 오스트리아 등의 국가들이 산전 톡소플라즈마증 스크리닝 프로그램을 정기적으로 실시하고 있으며 조기 진단을 크게 뒷받침하여 시장 개척을 촉진하고 있습니다. 유럽질병예방관리센터(ECDC)에 따르면 선천성 톡소플라즈마증은 특히 감염률이 높은 동유럽에서는 공중보건 전략에 중요한 초점이 되고 있습니다. 북미에서는 CDC는 공중보건국 및 진단 연구소와의 협력 하에 임산부와 면역 결핍자에 대한 인식 향상과 예방 검사를 추진하고 있습니다. 브라질에서 보건부는 선천성 감염증 대책 프로그램 하에서 톡소플라즈마증의 감시를 강화하고 공립 병원에서 진단 서비스에 대한 접근을 강화하고 있습니다. 2024년에는 브라질과 아르헨티나에서 지역에 뿌리를 둔 혈청학적 개발을 추진하기 위한 대학 병원과 진단 시약 제공업체와의 협력 관계가 보고되었습니다. 이러한 지역 특유의 이니셔티브와 조직적 제휴는 세계 의료 시스템 전반에서 톡소플라즈마증의 검출 및 관리 개선에 꾸준히 기여하고 있습니다.

톡소플라즈마증 검사 시장 - 경쟁 구도

톡소플라즈마증 검사 시장은 여러 진단기업과 연구 기관들이 검사 감도의 향상과 가격 경쟁력 실현에 주력하고 있으며, 경쟁은 적당 수준으로 이뤄지고 있습니다. Bio-Rad Laboratories, Abbott 및 DiaSorin과 같은 주요 개발 회사는 학술 기관 및 공중 보건 기관과 협력하여 혈청학적 분석 개발을 진행하고 있습니다. 2024년 DiaSorin은 밀라노 대학과 제휴하여 임신 중 조기 톡소플라즈마증 검출을 위한 IgG 가용성 검사를 개선했습니다. 마찬가지로 파스퇴르 연구소는 프랑스의 신흥 진단 기업과 협력하여 저자원 환경을 위한 신속한 검사 키트의 혁신을 지원합니다. 한편, Abbot은 T. gondii를 포함한 기생충 감염에 대응하기 위해 병원체 특이적 PCR 플랫폼을 통합하여 분자진단 부문을 확대했습니다. 지역 수준에서 브라질의 Fiocruz는 지역 생명 공학 회사와 협력하여 ELISA 검사 키트를 제조하고 수입 진단에 대한 의존도를 줄였습니다. 이러한 전략적 제휴 및 민관 파트너십은 세계적인 검사 인프라를 강화하고 보다 효율적인 톡소플라즈마증 진단제의 채용을 가속화하고 있습니다.

목차

제1장 톡소플라즈마증 검사 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 분석
  • 경쟁 인사이트

제3장 톡소플라즈마증 검사의 주요 시장 동향

  • 시장 성장 촉진 요인
  • 시장 성장 억제 요인
  • 시장 기회
  • 시장 전망 동향

제4장 톡소플라즈마증 검사 업계의 연구

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 맵핑
  • 규제 틀 분석

제5장 톡소플라즈마증 검사 시장 : 높아지는 지정학적 긴장의 영향

  • COVID-19 팬데믹의 영향
  • 러시아-우크라이나 전쟁의 영향
  • 중동 분쟁의 영향

제6장 톡소플라즈마증 검사 시장 상황

  • 톡소플라즈마증 검사 시장 점유율 분석(2024년)
  • 주요 제조업체별 분석 데이터
    • 기존 기업의 분석
    • 신흥 기업의 분석

제7장 톡소플라즈마증 검사 시장 - 제품 유형별

  • 개요
    • 제품 유형별 부문 점유율 분석
    • 검사 키트
    • 시약
    • 기기 및 분석장치
    • 소프트웨어 솔루션

제8장 톡소플라즈마증 검사 시장 - 검사 유형별

  • 개요
    • 검사 유형별 부문 점유율 분석
    • 혈청학적 검사
    • 분자 검사
    • 조직학적 검사
    • 기타

제9장 톡소플라즈마 검사 시장 - 기술별

  • 개요
    • 기술별 부문 점유율 분석
    • 효소 면역 측정(ELISA)
    • 중합효소 연쇄반응(PCR)
    • 기타

제10장 톡소플라즈마증 검사 시장 - 샘플 유형별

  • 개요
    • 샘플 유형별 부문 점유율 분석
    • 혈액
    • 양수
    • 뇌척수액
    • 기타

제11장 톡소플라즈마증 검사 시장 - 최종 사용자별

  • 개요
    • 최종 사용자별 부문 점유율 분석
    • 병원
    • 진단 실험실
    • 연구 기관
    • 재택 케어 환경

제12장 톡소플라즈마증 검사 시장 - 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 네덜란드
    • 스웨덴
    • 러시아
    • 폴란드
    • 기타
  • 아시아태평양
    • 개요
    • 아시아태평양의 주요 제조업체
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 인도네시아
    • 태국
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 튀르키예
    • 알제리
    • 이집트
    • 기타

제13장 주요 벤더 분석 - 톡소플라즈마증 검사 업계

  • 경쟁 대시보드
    • 경쟁 벤치마킹
    • 경쟁 포지셔닝
  • 기업 프로파일
    • Abbott Laboratories
    • ARUP Laboratories
    • Becton, Dickinson and Company
    • bioMerieux
    • Bio-Rad Laboratories
    • Creative Diagnostics
    • Danaher Corporation
    • DiaSorin
    • F. Hoffmann-La Roche
    • Luminex Corporation
    • NovaTec Immundiagnostica
    • Omega Diagnostics
    • Ortho Clinical Diagnostics
    • QIAGEN
    • Randox Laboratories
    • Siemens Healthineers
    • Thermo Fisher Scientific
    • Trinity Biotech
    • Vircell
    • ZEUS Scientific
    • 기타

제14장 애널리스트의 종합적 전망

CSM 25.09.25

Toxoplasmosis Testing Market size was valued at US$ 1,267 Million in 2024, expanding at a CAGR of 9.1% from 2025 to 2032.

The Toxoplasmosis Testing Market involves diagnostic procedures to detect Toxoplasma gondii infection, primarily through serological and molecular tests. Market growth is driven by increasing cases of toxoplasmosis in immunocompromised patients, pregnant women, and organ transplant recipients, especially in regions with limited sanitation and awareness. Rising prenatal screening initiatives, particularly in Europe and South America, and the use of nucleic acid amplification tests (NAATs) in diagnostic labs are bolstering demand. However, the market faces restraints such as underreporting, limited public health surveillance, and inconsistent testing practices in low-income regions. On the opportunity front, growing R&D funding, technological improvements in PCR and ELISA platforms, and collaborations between diagnostic companies and public health agencies (e.g., CDC and WHO) are expected to support market expansion over the coming years.

Toxoplasmosis Testing Market- Market Dynamics

Rising Prenatal Screening and Diagnostic Advancements Fuel Toxoplasmosis Testing Market Growth

The toxoplasmosis testing market is gaining momentum due to the increasing emphasis on prenatal care and infectious disease management. According to the CDC, toxoplasmosis affects over 40 million people in the U.S., though most remain asymptomatic. Pregnant women and immunocompromised individuals are particularly at risk, prompting regular screening protocols in countries like France, Austria, and Brazil. In 2023, the European Centre for Disease Prevention and Control (ECDC) highlighted rising awareness campaigns and improved diagnostics in Eastern Europe to reduce congenital infections. Simultaneously, initiatives like the WHO's efforts on foodborne parasitic diseases have led to improved public health strategies, especially in developing nations. Growing collaborations between diagnostic labs and hospitals, such as standardized serological testing in public health clinics, are also contributing to market expansion.

Toxoplasmosis Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.1% over the forecast period (2025-2032)

Based on product type segmentation, Test kits were predicted to show maximum market share in the year 2024

Based on Test Type segmentation, Serological tests were the leading Test Type in 2024

Based on Technology segmentation, Enzyme-Linked Immunosorbent Assay (ELISA) was the leading Technology in 2024

Based on Sample Type segmentation, Blood was the leading Sample Type in 2024

Based on end user segmentation, Hospitals were the leading end user in 2024

On the basis of region, North America was the leading revenue generator in 2024

Toxoplasmosis Testing Market- Segmentation Analysis:

The Global Toxoplasmosis Testing Market is segmented on the basis of Product Type, Test Type, Technology, Sample Type, End User, and Region.

The market is divided into four categories based on product type: Test Kits, Reagents, Instruments and Analyzers, and Software Solutions. Test kits held the highest priority due to their widespread use in clinical and point-of-care diagnostics. Reagents followed, driven by recurring demand. Instruments and analyzers ranked next, while software solutions held a supportive yet emerging role in result interpretation.

The market is divided into three categories based on Test Type: Serological Tests, Molecular Tests, Histological Tests, and Other. Serological tests led the market due to their cost-effectiveness and broad clinical use. Molecular tests followed closely with rising adoption in reference labs. Histological tests were less preferred, while other test types held minimal market share.

Toxoplasmosis Testing Market- Geographical Insights

In Europe, countries such as France and Austria have implemented routine prenatal toxoplasmosis screening programs, significantly boosting early diagnosis and driving market development. According to the European Centre for Disease Prevention and Control (ECDC), congenital toxoplasmosis remains a critical focus in public health strategies, especially in Eastern Europe, where infection rates are higher. In North America, the CDC promotes awareness and preventive testing among pregnant women and immunocompromised individuals, supported by collaborations with public health departments and diagnostic labs. In Brazil, the Ministry of Health has strengthened toxoplasmosis surveillance under its congenital infection control program, enhancing access to diagnostic services in public hospitals. In 2024, collaborations between university hospitals and diagnostic reagent providers were reported in Brazil and Argentina to advance localized serology development. These region-specific initiatives and institutional alliances are steadily contributing to the improved detection and control of toxoplasmosis across global healthcare systems.

Toxoplasmosis Testing Market- Competitive Landscape:

The toxoplasmosis testing market is moderately competitive, with several diagnostic firms and research institutions focused on enhancing test sensitivity and affordability. Key players like Bio-Rad Laboratories, Abbott, and DiaSorin continue to advance serological assay development in collaboration with academic and public health institutions. In 2024, DiaSorin partnered with the University of Milan to refine IgG avidity testing for early toxoplasmosis detection in pregnancy. Similarly, the Pasteur Institute has collaborated with diagnostic startups in France to support rapid test kit innovation for low-resource settings. Meanwhile, Abbott expanded its molecular diagnostics division by integrating pathogen-specific PCR platforms to cover parasitic infections, including T. gondii. On the regional level, Brazil's Fiocruz has worked with local biotech firms to produce ELISA test kits, reducing reliance on imported diagnostics. Such strategic alliances and public-private partnerships are strengthening the global testing infrastructure and accelerating the adoption of more efficient toxoplasmosis diagnostics.

Recent Developments:

In May 2024, the University of Chicago and LDBIO Diagnostics introduced a rapid point-of-care test, the Toxoplasma ICT IgG-IgM, offering accurate detection within 30 minutes from a finger-prick, with over 97.5% sensitivity and 100% specificity, effectively reducing false positives and improving prenatal screening accuracy.

In May 2025, scientists at the National Institute of Animal Biotechnology (NIAB) in Hyderabad used CRISPR-based genetic manipulation to pinpoint a Toxoplasma gondii protein that could be key in preventing zoonotic transmission and congenital toxoplasmosis-an effort aligned with WHO and FAO priorities on foodborne parasitic diseases.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TOXOPLASMOSIS TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • ARUP Laboratories
  • Becton, Dickinson and Company
  • bioMerieux
  • Bio-Rad Laboratories
  • Creative Diagnostics
  • Danaher Corporation
  • DiaSorin
  • F. Hoffmann-La Roche
  • Luminex Corporation
  • NovaTec Immundiagnostica
  • Omega Diagnostics
  • Ortho Clinical Diagnostics
  • QIAGEN
  • Randox Laboratories
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Trinity Biotech
  • Vircell
  • ZEUS Scientific
  • Others

GLOBAL TOXOPLASMOSIS TESTING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Test Kits
  • Reagents
  • Instruments and Analyzers
  • Software Solutions

GLOBAL TOXOPLASMOSIS TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Serological Tests
  • Molecular Tests
  • Histological Tests
  • Other

GLOBAL TOXOPLASMOSIS TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Polymerase Chain Reaction (PCR)
  • Others

GLOBAL TOXOPLASMOSIS TESTING MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Blood
  • Amniotic Fluid
  • Cerebrospinal Fluid
  • Other

GLOBAL TOXOPLASMOSIS TESTING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Research Institutions
  • Homecare Settings

GLOBAL TOXOPLASMOSIS TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Toxoplasmosis Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Toxoplasmosis Testing Market Snippet by Product Type
    • 2.1.2. Toxoplasmosis Testing Market Snippet by Test Type
    • 2.1.3. Toxoplasmosis Testing Market Snippet by Technology
    • 2.1.4. Toxoplasmosis Testing Market Snippet by Sample Type
    • 2.1.5. Toxoplasmosis Testing Market Snippet by End User
    • 2.1.6. Toxoplasmosis Testing Market Snippet by Country
    • 2.1.7. Toxoplasmosis Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Toxoplasmosis Testing Key Market Trends

  • 3.1. Toxoplasmosis Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Toxoplasmosis Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Toxoplasmosis Testing Market Opportunities
  • 3.4. Toxoplasmosis Testing Market Future Trends

4. Toxoplasmosis Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Toxoplasmosis Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Toxoplasmosis Testing Market Landscape

  • 6.1. Toxoplasmosis Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Toxoplasmosis Testing Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Test Kits
    • 7.1.3. Reagents
    • 7.1.4. Instruments and Analyzers
    • 7.1.5. Software Solutions

8. Toxoplasmosis Testing Market - By Test Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 8.1.2. Serological Tests
    • 8.1.3. Molecular Tests
    • 8.1.4. Histological Tests
    • 8.1.5. Other

9. Toxoplasmosis Testing Market - By Technology

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 9.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
    • 9.1.3. Polymerase Chain Reaction (PCR)
    • 9.1.4. Others

10. Toxoplasmosis Testing Market - By Sample Type

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Sample Type, 2024 & 2032 (%)
    • 10.1.2. Blood
    • 10.1.3. Amniotic Fluid
    • 10.1.4. Cerebrospinal Fluid
    • 10.1.5. Other Body Fluids

11. Toxoplasmosis Testing Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 11.1.2. Hospitals
    • 11.1.3. Diagnostic Laboratories
    • 11.1.4. Research Institutions
    • 11.1.5. Homecare Settings

12. Toxoplasmosis Testing Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Toxoplasmosis Testing Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Toxoplasmosis Testing Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Toxoplasmosis Testing Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Toxoplasmosis Testing Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Toxoplasmosis Testing Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Toxoplasmosis Testing Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Abbott Laboratories
    • 13.2.2. ARUP Laboratories
    • 13.2.3. Becton, Dickinson and Company
    • 13.2.4. bioMerieux
    • 13.2.5. Bio-Rad Laboratories
    • 13.2.6. Creative Diagnostics
    • 13.2.7. Danaher Corporation
    • 13.2.8. DiaSorin
    • 13.2.9. F. Hoffmann-La Roche
    • 13.2.10. Luminex Corporation
    • 13.2.11. NovaTec Immundiagnostica
    • 13.2.12. Omega Diagnostics
    • 13.2.13. Ortho Clinical Diagnostics
    • 13.2.14. QIAGEN
    • 13.2.15. Randox Laboratories
    • 13.2.16. Siemens Healthineers
    • 13.2.17. Thermo Fisher Scientific
    • 13.2.18. Trinity Biotech
    • 13.2.19. Vircell
    • 13.2.20. ZEUS Scientific
    • 13.2.21. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제